ProMIS Neurosciences Inc. (PMN) stock
PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.31+0.02 (+0.61%)
Close on Nov 16, 2026Market cap $29.68MP/E –Yield –
ProMIS Neurosciences total assets
Total assets on the balance sheet at the end of each period.
ProMIS Neurosciences's total assets was $56.69M at Jun 30, 2026. For fiscal 2025 it was $9.18M, down 51.4% from the year before. The highest annual figure on record is $18.91M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.18M | -51.4% |
| FY2024 | Dec 31, 2024 | $18.91M | +38.9% |
| FY2023 | Dec 31, 2023 | $13.62M | +96.7% |
| FY2022 | Dec 31, 2022 | $6.92M | -61.0% |
| FY2021 | Dec 31, 2021 | $17.75M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $56.69M | +496.2% |
| Q1 FY2026 | Mar 31, 2026 | $67.41M | +394.0% |
| Q4 FY2025 | Dec 31, 2025 | $9.18M | -51.4% |
| Q3 FY2025 | Sep 30, 2025 | $21.46M | -12.5% |
| Q2 FY2025 | Jun 30, 2025 | $9.51M | +574.6% |
| Q1 FY2025 | Mar 31, 2025 | $13.65M | +284.6% |
| Q4 FY2024 | Dec 31, 2024 | $18.91M | +38.9% |
| Q3 FY2024 | Sep 30, 2024 | $24.51M | +37.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.41M | -5.9% |
| Q1 FY2024 | Mar 31, 2024 | $3.55M | -19.9% |
| Q4 FY2023 | Dec 31, 2023 | $13.62M | +96.7% |
| Q3 FY2023 | Sep 30, 2023 | $17.88M | +232.2% |
| Q2 FY2023 | Jun 30, 2023 | $1.50M | -85.3% |
| Q1 FY2023 | Mar 31, 2023 | $4.43M | -75.0% |
| Q4 FY2022 | Dec 31, 2022 | $6.92M | – |
| Q3 FY2022 | Sep 30, 2022 | $5.38M | – |
| Q2 FY2022 | Jun 30, 2022 | $10.19M | – |
| Q4 FY2021 | Dec 31, 2021 | $17.75M | – |
See a number that looks wrong?